Hawkins, Inc. Reports First Quarter Fiscal 2025 Results

Rhea-AI Summary

Hawkins, Inc. (Nasdaq: HWKN) reported record Q1 FY2025 results with revenue growing 2% to $255.9 million, driven by a 25% increase in Water Treatment segment sales. Diluted EPS rose 23% to $1.38, while adjusted EBITDA increased 25% to $50.9 million. Gross profit grew 24% to $64.7 million, with all three segments showing double-digit growth. The company completed two acquisitions in the Water Treatment segment, expanding its geographic reach. Hawkins' CEO Patrick H. Hawkins highlighted the company's strong performance, with Water Treatment becoming the largest reporting segment and profitability growing over 20%. The company's balance sheet remains strong with a leverage ratio of 0.84x.

Positive

• Record quarterly results for revenue, gross profit, operating income, net income, diluted EPS, and adjusted EBITDA
• Water Treatment segment revenue grew 25% year-over-year
• Gross profit increased 24% to $64.7 million, with all three segments showing double-digit growth
• Diluted EPS increased 23% to $1.38 per share
• Adjusted EBITDA rose 25% to $50.9 million
• Completed two acquisitions in the Water Treatment segment, expanding geographic reach
• Strong balance sheet with a leverage ratio of 0.84x

Negative

• Industrial segment sales decreased 15% due to lower selling prices and volume pressure
• Health and Nutrition segment sales decreased 3% due to lower sales of manufactured products
• LIFO reserve increased, decreasing gross profit by $0.4 million
• Selling, general and administrative expenses increased 28% to $24.9 million

Financial Analyst

Hawkins, Inc. has delivered an impressive first quarter for fiscal 2025, showcasing strong financial performance across key metrics. The company reported record results in revenue, gross profit, operating income, net income, diluted EPS and adjusted EBITDA.

Notable highlights include:

• Revenue growth of 2% to $255.9 million, primarily driven by the Water Treatment segment's 25% increase.
• Gross profit surge of 24% to $64.7 million, with all three segments experiencing double-digit growth.
• Diluted EPS increase of 23% to $1.38 per share.
• Adjusted EBITDA growth of 25% to $50.9 million.

The company's strategic focus on higher-margin businesses and recent acquisitions in the Water Treatment segment are paying off. Despite revenue decreases in the Industrial and Health and Nutrition segments, improved product mix and pricing discipline led to increased profitability across all segments.

Hawkins' balance sheet remains strong with a leverage ratio of 0.84x, providing flexibility for future growth initiatives. The company's ability to generate substantial cash flow ($17.6 million from operations) while funding acquisitions, capital expenditures and shareholder returns is commendable.

Overall, Hawkins' Q1 results demonstrate robust execution of its strategy, positioning the company well for continued growth and profitability in the coming quarters.

Market Research Analyst

Hawkins' Q1 fiscal 2025 results reveal interesting market dynamics and strategic positioning:

• The Water Treatment segment has become the largest reporting segment, indicating a shift in the company's revenue mix and potentially reflecting broader industry trends towards water management solutions.
• The Industrial segment faced headwinds due to lower commodity costs, resulting in reduced selling prices. This highlights the segment's sensitivity to raw material price fluctuations.
• The Health and Nutrition segment saw a slight decline due to product mix changes, suggesting evolving customer preferences or market demands in this space.

Hawkins' acquisition strategy, particularly in the Water Treatment segment, is expanding its geographic reach and driving growth. The company completed six acquisitions in the last 12 months, demonstrating an aggressive expansion approach.

The company's ability to maintain volume in the Industrial segment despite pricing pressures is noteworthy, suggesting strong customer relationships and potentially a competitive advantage in service or product quality.

Hawkins' continued certification as a Great Place to Work for the fourth consecutive year is a positive indicator for talent retention and attraction, which can be important in specialized chemical industries.

Looking ahead, management's expectation of continued profitability growth across all segments suggests confidence in their strategic direction and market positioning. However, investors should monitor how the company navigates potential challenges such as integration of acquired businesses and any shifts in commodity prices or regulatory environments.

ROSEVILLE, Minn., July 31, 2024 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 30, 2024, its first quarter of fiscal 2025.

First Quarter Fiscal Year 2025 Highlights:

• Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share (“EPS”) and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure.
• Revenue growth of 2% driven by Water Treatment segment growth of 25% over the same period of the prior year.
• Gross profit increase of 24% over the same period of the prior year, with all three segments having double-digit growth.
• Diluted EPS increase of $0.26, or 23%, to $1.38 per share.
• Adjusted EBITDA, a non-GAAP measure, of $50.9 million, a 25% increase over the same period of the prior year. Trailing 12-month adjusted EBITDA exceeds $153 million.
• As previously announced, closed on two acquisitions in the first quarter, further expanding our geographic reach within our Water Treatment segment.
• For the fourth year in a row, Hawkins was certified as a Great Place to Work.
  

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“We are extremely pleased with our strong first quarter results with Water Treatment becoming our largest reporting segment, and our profitability continuing to grow by over 20% as we again experienced revenue and volume growth," said Patrick Hawkins, Chief Executive Officer and President. "Our record revenue of $256 million was driven by our acquired businesses in our Water Treatment segment. Revenue was down in our Industrial segment due primarily to reduced selling prices driven by lower commodity costs, with volumes relatively flat year over year. Revenue in our Health and Nutrition segment was also down slightly due to product mix changes. Gross profit increased double digits in all three of our segments due to the product mix and our continued focus on pricing discipline. Our continuing strategy of investing in higher margin business has helped drive the growth results we have experienced over the last five years. I am extremely proud of the entire Hawkins team, and the commitment of each and every employee has contributed to the success of our company.”

Mr. Hawkins, continued, “We closed two acquisitions in our Water Treatment segment in the first quarter, and have now completed six acquisitions in the last 12 months, expanding our geographic reach in this segment. We are also happy that we continue to realize synergies with each deal. Our balance sheet continues to be strong, and our leverage ratio at the end of the first quarter was 0.84x. Looking to the future, we expect all three segments to continue to grow profitability and we will continue to deliver on our strategy of investing in our higher margin businesses, while servicing the needs of our customers to the highest level possible.”

First Quarter Financial Highlights:

NET INCOME

For the first quarter of fiscal 2025, the Company reported net income of $28.9 million, or $1.38 per diluted share, compared to net income for the first quarter of fiscal 2024 of $23.4 million, or $1.12 per diluted share.

REVENUE

Sales were $255.9 million for the first quarter of fiscal 2025, an increase of $4.8 million, or 2%, from sales of $251.1 million in the same period a year ago. Increased sales in our Water Treatment segment more than offset decreased sales in our Industrial and Health and Nutrition segments. Water Treatment segment sales increased $23.5 million, or 25%, to $117.2 million for the current quarter, from $93.7 million in the same period a year ago. Water Treatment sales increased as a result of added sales from our acquired businesses. Industrial segment sales decreased $17.7 million, or 15%, to $103.2 million for the current quarter, from $120.9 million in the same period a year ago. The decrease in sales was primarily driven by lower selling prices on certain products driven by lower raw material costs and volume pressure. Health and Nutrition segment sales decreased $1.1 million, or 3.0%, to $35.5 million for the current quarter, from $36.6 million in the same period a year ago. Health and Nutrition sales decreased as a result of lower sales of our manufactured products, largely offset by increased sales of our specialty distributed products.

GROSS PROFIT

Gross profit increased $12.7 million, or 24%, to $64.7 million, or 25% of sales, for the current quarter, from $52.0 million, or 21% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.4 million due primarily to an increase in our forecasted year-end quantities. In the same quarter a year ago, the LIFO reserve decreased, and gross profit increased, by $0.2 million. Gross profit for the Water Treatment segment increased $8.6 million, or 33%, to $35.0 million, or 30% of sales, for the current quarter, from $26.4 million, or 28% of sales, in the same period a year ago. Water Treatment segment gross profit increased primarily as a result of increased sales from our acquired businesses. Gross profit for the Industrial segment increased $2.6 million, or 13%, to $21.9 million, or 21% of sales, for the current quarter, from $19.3 million, or 16% of sales, in the same period a year ago. Industrial segment gross profit increased as a result of improved unit margins on certain products. Gross profit for our Health and Nutrition segment increased $1.5 million, or 24%, to $7.8 million, or 22% of sales, for the current quarter, from $6.3 million, or 17% of sales, in the same period a year ago. Health and Nutrition segment gross profit increased as a result of improved margins on certain products.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative expenses increased $5.4 million, or 28%, to $24.9 million, or 10% of sales, for the current quarter, from $19.5 million, or 8% of sales, in the same period a year ago. Expenses increased primarily due to added costs from the acquired businesses in our Water Treatment segment and increased variable pay.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended June 30, 2024 was $50.9 million, an increase of $10.0 million, or 25%, from $40.9 million in the same period a year ago.

INCOME TAXES

Our effective income tax rate was 25% for the current quarter and 26% for the same period a year ago. The effective tax rate in the first quarter of both years was impacted by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.

BALANCE SHEET

During the first quarter, our working capital was $24 million higher than the end of fiscal 2024 due primarily to increased customer receivable balances, increased inventory and lower liabilities due to the payment of certain year-end accruals in the first quarter. During the quarter, net borrowings of $35.0 million and $17.6 million of operating cash flow was used to fund $25.4 million of acquisition spending for the acquisitions of Intercoastal Trading, Inc. and Wofford Water Service, Inc., capital spending of $10.6 million, stock repurchases of $9.1 million and dividend payments of $3.4 million. Our total debt outstanding at the end of the first quarter was $134.0 million and our leverage ratio was 0.84x our trailing twelve-month proforma adjusted EBITDA, as compared to 0.66x of trailing twelve-month adjusted EBITDA at the end of fiscal 2024.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 60 facilities in 27 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $919 million of revenue in fiscal 2024 and has approximately 950 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.

Adjusted EBITDA	Three Months Ended
(In thousands)	June 30, 2024				July 2, 2023
Net Income (GAAP)	$	28,879			$	23,430
Interest expense, net		1,263				1,148
Income tax expense		9,808				8,246
Amortization of intangibles		2,802				1,670
Depreciation expense		6,527				5,437
Non-cash compensation expense		1,467				959
Non-recurring acquisition expenses		188				—
Adjusted EBITDA	$	50,934			$	40,890

HAWKINS, INC. CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (In thousands, except share and per-share data)
	Three Months Ended
	June 30, 2024				July 02, 2023
Sales	$	255,879			$	251,120
Cost of sales		(191,224	)			(199,129	)
Gross profit		64,655				51,991
Selling, general and administrative expenses		(24,864	)			(19,504	)
Operating income		39,791				32,487
Interest expense, net		(1,263	)			(1,148	)
Other income		159				337
Income before income taxes		38,687				31,676
Income tax expense		(9,808	)			(8,246	)
Net income	$	28,879			$	23,430
Weighted average number of shares outstanding - basic		20,816,479				20,907,724
Weighted average number of shares outstanding - diluted		20,914,085				21,012,788
Basic earnings per share	$	1.39			$	1.12
Diluted earnings per share	$	1.38			$	1.12
Cash dividends declared per common share	$	0.16			$	0.15

HAWKINS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share data)
	June 30, 2024				March 31, 2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	8,887			$	7,153
Trade accounts receivables, net		126,398				114,477
Inventories		81,199				74,600
Prepaid expenses and other current assets		5,503				6,596
Total current assets		221,987				202,826
PROPERTY, PLANT, AND EQUIPMENT:		396,244				386,648
Less accumulated depreciation		182,604				177,774
Net property, plant, and equipment		213,640				208,874
OTHER ASSETS:
Right-of-use assets		12,157				11,713
Goodwill		114,046				103,399
Intangible assets, net of accumulated amortization		124,563				116,626
Deferred compensation plan asset		11,365				9,584
Other		4,980				4,912
Total other assets		267,111				246,234
Total assets	$	702,738			$	657,934
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable — trade	$	47,795			$	56,387
Accrued payroll and employee benefits		12,501				19,532
Income tax payable		11,751				1,943
Current portion of long-term debt		9,913				9,913
Environmental remediation		7,700				7,700
Other current liabilities		8,332				7,832
Total current liabilities		97,992				103,307
LONG-TERM DEBT, LESS CURRENT PORTION		123,840				88,818
LONG-TERM LEASE LIABILITY		9,816				9,530
PENSION WITHDRAWAL LIABILITY		3,443				3,538
DEFERRED INCOME TAXES		22,367				22,406
DEFERRED COMPENSATION LIABILITY		12,244				11,764
EARNOUT LIABILITY		11,577				11,235
OTHER LONG-TERM LIABILITIES		241				1,310
Total liabilities		281,520				251,908
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,734,331 and 20,790,261 shares issued and outstanding as of June 30, 2024 and March 31, 2024, respectively		207				208
Additional paid-in capital		27,932				38,154
Retained earnings		390,070				364,549
Accumulated other comprehensive income		3,009				3,115
Total shareholders’ equity		421,218				406,026
Total liabilities and shareholders’ equity	$	702,738			$	657,934

HAWKINS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands)
	Three Months Ended
	June 30, 2024				July 2, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	28,879			$	23,430
Reconciliation to cash flows:
Depreciation and amortization		9,329				7,107
Change in fair value of earnout liability		342				—
Operating leases		782				534
Gain on deferred compensation assets		(159	)			(337	)
Stock compensation expense		1,467				959
Other		(65	)			26
Changes in operating accounts providing (using) cash:
Trade receivables		(10,576	)			(9,055	)
Inventories		(6,037	)			11,839
Accounts payable		(7,300	)			(537	)
Accrued liabilities		(8,949	)			(9,075	)
Lease liabilities		(834	)			(580	)
Income taxes		9,808				8,255
Other		899				2,300
Net cash provided by operating activities		17,586				34,866
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment		(10,649	)			(7,873	)
Acquisitions		(25,400	)			—
Other		245				44
Net cash used in investing activities		(35,804	)			(7,829	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid		(3,358	)			(3,160	)
New shares issued		—				1,147
Payroll taxes paid in exchange for shares withheld		(2,541	)			(2,140	)
Shares repurchased		(9,149	)			—
Payments on revolving loan		(10,000	)			(23,400	)
Proceeds from revolving loan borrowings		45,000				—
Net cash provided by (used in) financing activities		19,952				(27,553	)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		1,734				(516	)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		7,153				7,566
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	8,887			$	7,050
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest	$	1,347			$	1,221
Noncash investing activities - capital expenditures in accounts payable	$	1,015			$	4,771

HAWKINS, INC. REPORTABLE SEGMENTS (UNAUDITED) (In thousands)
	Water Treatment			Industrial			Health and Nutrition			Total
Three months ended June 30, 2024:
Sales	$	117,176		$	103,202		$	35,501		$	255,879
Gross profit		34,955			21,876			7,824			64,655
Selling, general, and administrative expenses		14,166			6,639			4,059			24,864
Operating income		20,789			15,237			3,765			39,791
Three months ended July 2, 2023:
Sales	$	93,651		$	120,873		$	36,596		$	251,120
Gross profit		26,408			19,306			6,277			51,991
Selling, general, and administrative expenses		9,126			6,575			3,803			19,504
Operating income		17,282			12,731			2,474			32,487

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:	Jeffrey P. Oldenkamp Executive Vice President and Chief Financial Officer 612/331-6910 ir@HawkinsInc.com

FAQ

What was Hawkins Inc's (HWKN) revenue growth in Q1 FY2025?

Hawkins Inc (HWKN) reported a 2% revenue growth in Q1 FY2025, with total sales reaching $255.9 million.

How much did Hawkins Inc's (HWKN) diluted EPS increase in Q1 FY2025?

Hawkins Inc's (HWKN) diluted EPS increased by 23% to $1.38 per share in Q1 FY2025.

What was the growth rate of Hawkins Inc's (HWKN) Water Treatment segment in Q1 FY2025?

Hawkins Inc's (HWKN) Water Treatment segment sales increased by 25% in Q1 FY2025.

How many acquisitions did Hawkins Inc (HWKN) complete in Q1 FY2025?

Hawkins Inc (HWKN) completed two acquisitions in the Water Treatment segment during Q1 FY2025.

What was Hawkins Inc's (HWKN) adjusted EBITDA for Q1 FY2025?

Hawkins Inc's (HWKN) adjusted EBITDA for Q1 FY2025 was $50.9 million, a 25% increase year-over-year.